Evidence map›Paper›PMID 29093266›Full record

ArticleJCI insight2017

Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications.

Frédéric Torossian, Bernadette Guerton, Adrienne Anginot, Kylie A Alexander, Christophe Desterke, Sabrina Soave, Hsu-Wen Tseng, Nassim Arouche, Laetitia Boutin, Irina Kulina and 15 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JCI insight, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04273347 (Incidence of Neurogenic Paraosteoarthropathies), which is not on this map. Cited by 69 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 2 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04273347 unknown statusnot on this mapstarted 2023, after this paper: background citation

Incidence of Neurogenic Paraosteoarthropathies (NPOA) in a Population of Brain Traumatized and Spinal Cord Injured Patients and Specific Markers of Early Neurogenic Paraosteoarthropathies Development"

TypeobservationalSponsorAssistance Publique - Hôpitaux de ParisRan2023 to 2024Enrolled118ConditionsSpinal Cord Injuries, Injury, Brain, TraumaticArmsstandard of care for patient with brain trauma and spinal cord injury
3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 2 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. The significance of heterotopic ossification following total ankle arthroplasty: a systematic review and meta-analysis.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2024
    Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Interferon-JAK-STAT Axis in Bone Metabolism.Current osteoporosis reports · 2026
    Review
  10. The Role of Phagocytic Cells in the Achilles Tendon.International journal of molecular sciences · 2026
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 6 institutions in 2 countries.

Frédéric TorossianInserm UMR-S-MD1197, Paris 11 University, Paul Brousse Hospital, Villejuif, France.
Bernadette GuertonInserm UMR-S-MD1197, Paris 11 University, Paul Brousse Hospital, Villejuif, France.
Adrienne AnginotInserm UMR-S-MD1197, Paris 11 University, Paul Brousse Hospital, Villejuif, France.
Kylie A AlexanderMater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia.
Christophe DesterkeUMS33, Paris 11 University, Paul Brousse Hospital, Villejuif, France.
Sabrina SoaveInserm UMR-S-MD1197, Paris 11 University, Paul Brousse Hospital, Villejuif, France.
Hsu-Wen TsengMater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia.
Nassim AroucheInserm UMR-S-MD1197, Paris 11 University, Paul Brousse Hospital, Villejuif, France.
Laetitia BoutinInserm UMR-S-MD1197, Paris 11 University, Paul Brousse Hospital, Villejuif, France.
Irina KulinaMater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia.
Marjorie SalgaMater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia.
Beulah JoseMater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia.
Allison R PettitMater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia.
Denis ClayUMS33, Paris 11 University, Paul Brousse Hospital, Villejuif, France.
Nathalie RochetUniversité Côte d'Azur, CNRS, Inserm, Institut de Biologie Valrose, Nice, France.
Erica VlachosService de Médecine Physique et de Réadaptation, Paris 12 University, Garches, France.
Guillaume GenetService de Médecine Physique et de Réadaptation, Paris 12 University, Garches, France.
Charlotte DebaudUniversité de Versailles Saint-Quentin-en-Yvelines, Evolution of neuromuscular diseases: innovative concepts and practices, Inserm U1179, Montigny le Bretonneux, France.
Philippe DenormandieService de Médecine Physique et de Réadaptation, Paris 12 University, Garches, France.
François GenetUniversité de Versailles Saint-Quentin-en-Yvelines, Evolution of neuromuscular diseases: innovative concepts and practices, Inserm U1179, Montigny le Bretonneux, France.
Natalie A SimsSt. Vincent's Institute of Medical Research and Department of Medicine, St. Vincent's Hospital, The University of Melbourne, Fitzroy, Victoria, Australia.
Sébastien BanzetInserm UMR-S-MD1197, Paris 11 University, Paul Brousse Hospital, Villejuif, France.
Jean-Pierre LevesqueMater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia.
Jean-Jacques LatailladeInserm UMR-S-MD1197, Paris 11 University, Paul Brousse Hospital, Villejuif, France.
Marie-Caroline Le Bousse-KerdilèsInserm UMR-S-MD1197, Paris 11 University, Paul Brousse Hospital, Villejuif, France.
Inserm · FRTranslational Research Institute · AUUniversité Paris-Est Créteil · FRUniversité Paris-Saclay · FRCentre National de la Recherche Scientifique · FRSt Vincent's Hospital Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurogenic heterotopic ossification (NHO) is the formation of ectopic bone generally in muscles surrounding joints following spinal cord or brain injury. We investigated the mechanisms of NHO formation in 64 patients and a mouse model of spinal cord injury-induced NHO. We show that marrow from human NHOs contains hematopoietic stem cell (HSC) niches, in which mesenchymal stromal cells (MSCs) and endothelial cells provide an environment supporting HSC maintenance, proliferation, and differentiation. The transcriptomic signature of MSCs from NHOs shows a neuronal imprinting associated with a molecular network required for HSC support. We demonstrate that oncostatin M (OSM) produced by activated macrophages promotes osteoblastic differentiation and mineralization of human muscle-derived stromal cells surrounding NHOs. The key role of OSM was confirmed using an experimental model of NHO in mice defective for the OSM receptor (OSMR). Our results provide strong evidence that macrophages contribute to NHO formation through the osteogenic action of OSM on muscle cells within an inflammatory context and suggest that OSM/OSMR could be a suitable therapeutic target. Altogether, the evidence of HSCs in ectopic bones growing at the expense of soft tissue in spinal cord/brain-injured patients indicates that inflammation and muscle contribute to HSC regulation by the brain-bone-blood triad.

Indexed as

AnimalsAntigens, CD34Brain InjuriesCell DifferentiationCell ProliferationEndothelial CellsFemaleHematopoiesisHematopoietic Stem CellsHeterograftsHumansMacrophagesMesenchymal Stem CellsMiceMice, Inbred C57BLMice, KnockoutAntigens, CD34Oncostatin MOncostatin M Receptor beta SubunitOSMR protein, human

Identifiers

PMID29093266
PMCPMC5752299
OpenAlexW2766555128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.